![](/fileadmin/Content/NewsAndStories/2024/Rentschler_Biopharma_new_line_PR_SM.png)
Rentschler doubles cGMP capacity
According to a company spokesperson, the expansion in the main market for biopharmaceuticals doubles Rentschler's cGMP-compliant production capacity...
![](/fileadmin/_processed_/csm_Ohr_01cd9c4461.jpg)
Sensorion achieves milestones in Phase II trial
Following cochlear implantation, SENS-401, a 5HT3R antagonist that blocks the CalN pathway, reduced sudden hearing loss as measured by the...
![](/fileadmin/_processed_/csm_New-Expansion-Site-Rendering-in-Clayton-1_f5772ed7b0.jpg)
Novo Nordisk expands footprint in USA
Novo Nordisk realises a major expansion in Clayton, NC. The project will enhance Novo Nordisk's manufacturing capabilities with more than 1.4...
![](/fileadmin/_processed_/csm_SFactory01_Launch_044ec847f4.png)
Solar Foods starts Factory01
Following market authorisation in Singapore two years ago, the Finnish company Solar Foods Oy and the Japanese food giant Ajinomoto Group want to...
![](/fileadmin/_processed_/csm_Amphistar_c6faa8b918.jpg)
AmphiStar BV secures €6m to expand production
The infusion of €6m in new capital from ECBF, Qbic III and FFTF will empower AmphiStar to kickstart commercial biosurfactant production in...
![](/fileadmin/Content/NewsAndStories/2024/SciRhom_01_2_80_.png)
SciRhom GmbH closes €63m Series A financing
SciRhom GmbH’s Series A financing was co-led by Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners - new investor...
![](/fileadmin/Content/NewsAndStories/2024/National_Eye_Institute.png)
Seabelife SAS to develop next-gen dry AMD drug
French drug developer SeaBeLife SAS has bagged a €1.5m fund within the i-Nov 2024 innovation competition, which is part of the French government’s...